EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF DRUG REGISTRATION APPLICATION FOR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (CRM197, TT VECTOR)
INSIDE INFORMATION UPDATES ON 2023 PRELIMINARY ANNUAL RESULTS
ELECTIONS RELATING TO BOARD OF DIRECTORS, BOARD COMMITTEES AND BOARD OF SUPERVISORS
List of Directors and their Roles and Functions
Articles of Association
List of Directors and their Roles and Functions
POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
FURTHER ELABORATION OF CUMULATIVE VOTING SYSTEM TO BE ADOPTED FOR CERTAIN RESOLUTIONS PROPOSED AT THE 2024 FIRST EGM
INSIDE INFORMATION DECONSOLIDATION OF CANSINO SPH BIOLOGICS INC.
Monthly Return of Equity Issuer on Movements in Securities
1
10
11
12
13
14
52
津公网安备12011602300399
